
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
ITF Therapeutics is the US-based rare disease division of Italfarmaco S.p.A. Founded in 1938 in Milan, Italy, Italfarmaco is a private global pharmaceutical company that has led the successful development of many innovative therapeutic products approved for use by patients around the world. The company operates in more than 90 countries on five continents and continues to advance promising research to address unmet medical needs in a wide range of therapeutic areas. In January 2024, Italfarmaco launched ITF Therapeutics as a new division in the United States with a focus on the development and commercialization of products to treat rare...
Clinical development,clinical research,clinical study,clinical trial,dmd,drug development,duchenne,duchenne muscular dystrophy,healthcare,life sciences,muscular dystrophy,neuromuscular,neuromuscular disease,patient advocacy,pharmaceuticals,rare diseases,rare disorders,and research
Itf therapeutics llc operates in the Pharmaceutical manufacturing industry.
Itf therapeutics llc's revenue is 11m - 100m
Itf therapeutics llc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.